Why the study?
The HEART Pathway is validated for Emergency Department patients with chest pain, but it had not yet been tested in the prehospital setting.
Does a prehospital modified HEART Pathway (PMHP) with point-of-care troponin accurately predict 30-day major adverse cardiac events in adult patients with chest pain without STEMI?
Population
506 adults with chest pain without ST-segment elevation myocardial infarction
Comparison
Risk stratification via prehospital modified HEART Pathway into high, moderate, and low risk
Design
Prospective cohort study
Follow-up
30 days
Authors
Loading...
May support prehospital low-risk triage; hypothesis-generating and requires prospective validation before practice change.
Does a prehospital modified HEART Pathway (PMHP) with point-of-care troponin accurately predict 30-day major adverse cardiac events in adult patients with chest pain without STEMI?
A prehospital modified HEART Pathway using point-of-care troponin can identify low-risk chest pain patients with high negative predictive value for 30-day MACE, potentially allowing for more efficient EMS triage.
Stopyra et al. (2020) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: